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ABSTRACT 
 
Introduction 
         Chronic Kidney Disease (CKD) is a clinical syndrome that occurs when there is a 
gradual decline in renal function over time. Early detection and treatment are needed to 
prevent progression to kidney failure and complications such as coronary vascular 
disease. Beta-Trace Protein (BTP), also known as Prostaglandin D Synthase is a low 
molecular weight protein belongs to lipocalin family. It is produced in the choroid 
plexus of cerebrospinal fluid and it is completely eliminated by glomerular filtration. 
 
Aims and objectives 
1.  To estimate the serum level of Beta-Trace Protein in patients with chronic 
kidney disease and to compare them with healthy individuals 
 
2. To correlate the serum Beta-Trace Protein level with serum creatinine and 
Creatinine clearance 
 
3. To evaluate the correlation between serum Beta-Trace Protein level and other 
several known risk factors such as Body mass Index, Blood pressure, Random 
blood sugar and blood urea  
 
 
Materials and methods 
        The study was conducted at Thanjavur Medical College Hospital, Thanjavur. 
50 patients of known CKD (25 males and 25 females) were selected as cases from the 
outpatients and wards of the Department of Nephrology. 50 age and gender matched 
healthy individuals were selected as controls. 
        Blood samples were collected and analysed for serum BTP (ELISA), serum 
creatinine (JAFFE’S method), serum urea (urease- GLDH method) and Random blood 
sugar (GOD-POD method).  
 Calculated parameters:  
          Estimated creatinine clearance  =  (140- age) X Wt in Kg    
                                                                  72 X serum creatinine 
Multiply by 0.85 for females.    
 
Results  
         The results revealed that serum Beta-Trace Protein concentrations were found to 
be significantly increased in patients with Chronic Kidney Disease (mean 52.24 ± 29.6) 
when compared to the control group (mean 33.86 ± 12.1). When patients in different 
stages of Chronic Kidney Disease were compared, serum Beta-Trace Protein levels 
were found to be progressively increased from stage 3 to stage 5. This observation 
shows that serum Beta-Trace Protein increases as renal function declines and inversely 
correlated with Creatinine clearance (r = - 0.765). 
        Serum creatinine and blood urea were progressively increased in cases than 
controls and shows positive correlation with Beta-Trace Protein (r = 0.630 and r = 
0.721) respectively. 
        Random blood sugar and blood pressure were significantly increased in cases than 
controls which shows that CKD is more prevalent in DM and HT. 
Conclusion 
          The present study demonstrated that serum Beta-Trace Protein levels are 
progressively increased in patients with Chronic Kidney Disease. Hence it is used as a 
novel biomarker in the diagnosis and predictor of progression of Chronic Kidney 
Disease. 
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